Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP3 | P08254 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.43 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL73401 | 1.00 | MMP1 (0.47) | MMP1MMP2MMP3MMP8FDPS | |
| Pyrophosphoric Acid SCHEMBL73402 | 1.00 | MMP1 (0.47) | MMP1MMP2MMP3MMP8FDPS | |
| Pyrophosphoric Acid SCHEMBL490709 | 1.00 | MMP1 (0.47) | MMP1MMP2MMP3MMP8FDPS | |
| Pyrophosphoric Acid SCHEMBL28344128 | 0.93 | LPAR3 (0.47) | MMP1MMP2MMP3MMP8FDPS | |
| Triphosphate SCHEMBL5052601 | 0.91 | MMP1 (0.44) | MMP1MMP2MMP3MMP8FDPS | |
| Pyrophosphoric Acid SCHEMBL9547118 | 0.91 | LPAR3 (0.50) | FDPSBLMTDP1LPAR3LPAR2 | |
| Pyrophosphoric Acid SCHEMBL9547107 | 0.91 | LPAR3 (0.50) | FDPSBLMTDP1LPAR3LPAR2 | |
| Triphosphate SCHEMBL5052598 | 0.91 | MMP1 (0.44) | MMP1MMP2MMP3MMP8FDPS | |
| Pyrophosphoric Acid SCHEMBL28321370 | 0.89 | MMP1 (0.39) | MMP1MMP2MMP3MMP8FDPS | |
| SCHEMBL4845792 | 0.88 | MMP1 (0.41) | MMP1MMP2MMP3MMP8FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 481 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552827-B2 | Synthesis of an antiviral azasugar triphosphate | BIOCRYST PHARMACEUTICALS, INC. (US) | 2026-02-17 | — | — | US | claimed |
| US-20230303611-A1 | SYNTHESIS OF AN ANTIVIRAL AZASUGAR TRIPHOSPHATE | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2023-09-28 | — | — | US | claimed |
| US-20260069717-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | MODERNATX INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12552827-B2 | Synthesis of an antiviral azasugar triphosphate | BIOCRYST PHARMACEUTICALS, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| US-20250361260-A1 | NUCLEOTIDE ANALOGUES | SINGULAR GENOMICS SYSTEMS INC (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250215493-A1 | NUCLEOTIDES WITH ENZYMATICALLY CLEAVABLE 3'-O-GLYCOSIDE BLOCKING GROUPS FOR SEQUENCING | ILLUMINA, INC. | 2025-07-03 | — | — | US | disclosed |
| CN-115867560-B | Nucleosides and nucleotides having 3' acetal end-capping groups | 伊鲁米纳剑桥有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-12215122-B2 | Nucleotide analogues | Singular Genomics Systems, Inc. (US) | 2025-02-04 | — | — | US | disclosed |
| CN-119095984-A | Sequencing methods using 3' allyl-terminated nucleotides | 伊路米纳有限公司 | 2024-12-06 | — | — | CN | disclosed |
| US-20240400602-A1 | NUCLEOTIDE ANALOGUES | FIRST-CITIZENS BANK & TRUST COMPANY | 2024-12-05 | — | — | US | disclosed |
| US-20240383938-A1 | PHOSPHOROAMIDATE ESTERS, AND USE AND SYNTHESIS THEREOF | ROCHE SEQUENCING SOLUTIONS INC (US) | 2024-11-21 | — | — | US | disclosed |
| US-4780453-A | 3'-AZIDO-3'-DEOXYTHYMIDINE OR SALT THEREOF | BURROUGHS WELLCOME CO. (US) | 1988-10-25 | — | — | US | disclosed |
| EP-0286898-A2 | Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same | ENZO BIOCHEM, INC. (US) | 1988-10-19 | — | — | EP | disclosed |
| EP-0285950-A2 | A drug delivery conjugate | ENZO BIOCHEM, INC. (US) | 1988-10-12 | — | — | EP | disclosed |
| EP-0285058-A2 | Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same | ENZO BIOCHEM, INC. (US) | 1988-10-05 | — | — | EP | disclosed |
| EP-0285057-A2 | Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same | ENZO BIOCHEM, INC. (US) | 1988-10-05 | — | — | EP | disclosed |
| US-4724232-A | 3'-AZIDO-3'-DEOXYTHYMIDINE OR SALT THEREOF | BURROUGHS WELLCOME CO. (US) | 1988-02-09 | — | — | US | disclosed |
| EP-0235301-A1 | PYRIDOPYRIMIDINE NUCLEOTIDE DERIVATIVES | TEIJIN LIMITED (JP) | 1987-09-09 | — | — | EP | disclosed |
| US-4476301-A | Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1984-10-09 | — | — | US | disclosed |
| EP-0097373-A2 | Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same | ENZO BIOCHEM, INC. (US) | 1984-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12215122-B2 | Nucleotide analogues | NUDT1, POLN, TYMP | MMP1 4521/4885MMP2 4531/4885MMP3 4566/4885 |
| US-20260069717-A1 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | RNMT, RNGTT, NSUN2 | MMP1 4560/4885MMP2 3505/4885MMP3 3837/4885 |
| US-12552827-B2 | Synthesis of an antiviral azasugar triphosphate | MTAP, NSUN2, RNGTT | MMP1 3957/4885MMP2 3944/4885MMP3 4229/4885 |
| US-20240400602-A1 | NUCLEOTIDE ANALOGUES | ADAR, NUDT1, NSUN2 | MMP1 4302/4885MMP2 4268/4885MMP3 4066/4885 |
| US-20250361260-A1 | NUCLEOTIDE ANALOGUES | ADAR, NUDT1, NSUN2 | MMP1 4302/4885MMP2 4268/4885MMP3 4066/4885 |
| US-20250215493-A1 | NUCLEOTIDES WITH ENZYMATICALLY CLEAVABLE 3'-O-GLYCOSIDE BLOCKING GROUPS FOR SEQUENCING | RNGTT, UNG, DUT | MMP1 1762/4885MMP2 625/4885MMP3 538/4885 |
| US-20230303611-A1 | SYNTHESIS OF AN ANTIVIRAL AZASUGAR TRIPHOSPHATE | RNGTT, ADAR, MTAP | MMP1 2672/4885MMP2 1749/4885MMP3 2949/4885 |
| US-20240383938-A1 | PHOSPHOROAMIDATE ESTERS, AND USE AND SYNTHESIS THEREOF | PNKP, PNP, TYMP | MMP1 4803/4885MMP2 4567/4885MMP3 4752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.